Nuvation Bio Inc.
Heterocyclic compounds as adenosine antagonists
Last updated:
Abstract:
Aminopyrazine compounds as modulators of an adenosine receptor are provided. The compounds may find use as therapeutic agents for the treatment of diseases mediated through a G-protein-coupled receptor signaling pathway and may find particular use in oncology.
Status:
Grant
Type:
Utility
Filling date:
18 Jul 2018
Issue date:
8 Jun 2021